Tourette's Syndrome
22
1
1
12
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
13.6%
3 terminated out of 22 trials
80.0%
-6.5% vs benchmark
14%
3 trials in Phase 3/4
25%
3 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (22)
Physiological Investigations of Movement Disorders
Effects of Lactobacillus Plantarum PS128 in Patients With Tourette's Syndrome
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Exploring DBS Efficacy in Treatment-refractory Tourette's Syndrome
Optimising Anterior Pallidal Deep Brain Stimulation for Tourette's Syndrome
Brain-Behavior Interactions in Tic Suppression
Brain Tissue Collection for Neuropathological Studies
A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome
Psychosocial Intervention for Young Children With Chronic Tics
Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome
Hypersensitivity in Tourette Syndrome
N-acetylcysteine (NAC) for Children With Tourette Syndrome
Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder
Subthalamic Stimulation in Tourette's Syndrome
Ecopipam Treatment of Tourette Syndrome
Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Safety and Feasibility Study for the Treatment of Tourette Syndrome
Aripiprazole in the Treatment of Tourette's Syndrome
Safety Study of Galantamine in Tic Disorders
Brain Activation in Vocal and Motor Tics